Novel 5α‐steroid reductase (SRD5A3, type‐3) is overexpressed in hormone‐refractory prostate cancerMotohide Uemura, Hidewaki Nakagawa, Äkïhïko Okuyama et al.|Cancer Science|2007Cited by 259
5αDH‐DOC (5α‐dihydro‐deoxycorticosterone) activates androgen receptor in castration‐resistant prostate cancerMotohide Uemura, Hidewaki Nakagawa, Seijiro Honma et al.|Cancer Science|2010Cited by 16